The integration of artificial intelligence into healthcare has progressed significantly, moving beyond trial periods. As evidenced by a recent analysis from Alaap Shah, who co-chairs Epstein Becker Green’s AI Cross-Practice Working Group, AI solutions have become commonplace in various healthcare applications, including clinical scheduling, medication distribution, patient communication, and diagnostic decision-making.
According to Shah's findings, featured in the TechReg Chronicle, this transformation not only affects healthcare operations but also impacts financial institutions connected to the healthcare sector. These include entities involved in payment systems, insurance products, employer health plans, loans for medical providers, and financial tools aimed at healthcare consumers. As the regulatory and liability landscape continues to evolve, these financial organizations will undoubtedly feel the repercussions.
A Compliance Framework Lags Behind AI Advancements
Shah points out that the swift adoption of AI technologies has outpaced the existing regulatory frameworks designed to manage them. Federal agencies are currently working with regulatory models that are outdated. For instance, the Food and Drug Administration is increasing its oversight of AI tools that affect clinical decision-making, while the Department of Health and Human Services is examining how AI systems manage personal health data according to current privacy laws. Additionally, the Federal Trade Commission is taking an interest in how AI vendors present and promote their products.
States have begun to take individual action as well. California, Colorado, Utah, and others have initiated or suggested regulations governing AI usage in healthcare, resulting in differing compliance requirements across states. This places healthcare providers operating in multiple jurisdictions in a challenging position, as they must navigate a complex regulatory framework with no overarching federal standard.
Importance for FinTech in Healthcare
The analysis highlights the significance of vendor contracts in this evolving landscape. When an AI tool malfunctions, leading to regulatory scrutiny or claims of patient harm, the responsibility for that liability falls back to the contract terms. Healthcare organizations are keen to establish stringent indemnification clauses, audit rights for AI systems, and requirements for vendor notifications regarding significant model changes.
Data Privacy as a Central Concern
Shah emphasizes that patient data is the lifeblood of healthcare AI applications, making data governance a critical risk area. Federal privacy laws safeguard this data, and compliance requirements can be intricate. When third-party vendors utilize patient records for AI processing, formal data agreements must delineate permissible uses. Moreover, if patient data is leveraged to enhance a vendor's offerings beyond the established agreement, organizations may find themselves at risk.
The complexity of interoperability compounds these issues. AI enhances the capacity for healthcare systems to share data, but this increased data flow also broadens the potential for cybersecurity threats. As such, health systems are urged to consider AI-driven data exchanges as a unique cybersecurity risk category, a challenge that parallels those faced by financial services.
Best Practices for Governance
Organizations that are navigating this rapidly changing environment most effectively treat it as an enterprise risk management issue that requires board-level attention. This involves implementing internal frameworks that incorporate legal and compliance considerations into all AI deployment decisions, linking each AI application to the relevant regulatory frameworks, and revisiting these evaluations as needed. Contracts must clearly outline the responsibilities associated with AI operations, including modifications over time and liability in the event of issues.
Healthcare institutions demonstrating effective management and compliance of their AI initiatives are likely to have an advantage with payers, regulators, and partners. Conversely, those who disregard compliance risks facing legal challenges and reputational damage will find these risks escalating as regulatory enforcement intensifies.
Key Takeaways for Financial Leaders
Shah's insights extend to the financial sector, where rapid AI adoption in healthcare is unfolding alongside the development of governance structures. Vendor contracts with healthcare clients, the data transactions they incite, healthcare-related payment products, and implemented AI solutions all carry an expanding regulatory scope. Understanding one's position within the healthcare AI ecosystem is vital for effectively managing a contemporary financial services operation.
